View allAll Photos Tagged Biohacks
“Be yourself.
Be who you are.
Never change for others.”
/ SML.20121205.PHIL
/ #smlphil #ccby #smluniverse
I used to care about what people think about me. So I change the way I am for others. It drives me nuts.
In order to appear “normal” to people and be able to talk at half my normal rate, I started taking 40mg Strattera (ADHD medication) twice a day in 2007. Although people like it, I have also ceased to win any important international design awards because I also lose my creativity as a result. These days I minimize taking any. I noted that if I need to do any public speaking, if I just take 18mg on the morning then it's alright. Excessive Biohacking is bad for the soul.
In order to appeal to the body conscious gay community, I used to go to the gym 3x/week and had a professional personal trainer for two years. Did I feel good? Yes. Did he get me into shape? Yes. Did it increase the chance for me to be in love? No. Did I get happier? Yes and no. I did feel better but it is taking so much of my time that I ended up getting stressed out from not having the time to do my work—which is the most important thing in my life. I have thus decided that it is unimportant to me. I exercise these days from carrying all that photography equipment around town and in remote location. That works well.
Overtime I have stopped doing things just to please the crowd. I have principals. I make it my mission to talk about important issues which no one talks about. I make it my mission to blog about things which mainstream media will not cover. I have learned over time that being popular is unimportant to me. I am happy being on my own. If others don't like me it's ok. By being who I am I am able to do what I love. By being who I am I no longer waste time with people who are unimportant to me.
Self identity is something which defines who you are. Embrace it.
This is my first 'yeastogram' (or better said, the one that worked best) Big, big thanks to Günter Seyfried for teaching us this technique at the Instant Art: Biohacking Workshop and to the fellows at The Impossible Project Laboratory for organizing it.
This image is produced by growing normal backing yeast on a petri dish, creating a negative stencil to transfer the image and projecting UV light on the yeast to not let it grow wherever you want black.
Hopefully more to come soon!
When I met Eric Topol at Scripps Research, he greeted me with an easy calm, the sort of quiet steadiness that settles a room without ever trying to command it. There is no theatricality about him. No hint of the celebrity doctor, even though he easily could play that role. His curiosity comes first. You feel it immediately. He listens closely, as if the next idea might arrive from anywhere.
Topol has spent decades at the frontier of cardiovascular medicine, genomics, and digital health. He trained as a cardiologist at a time when heart attacks were often a sudden, devastating surprise. Much of his early work focused on clot-busting therapies and transforming acute cardiac care. That alone would have secured a distinguished career. But he did not stop there. He moved into genetics and then into the rapidly evolving intersection of medicine and data, asking how sequencing, wearable sensors, and artificial intelligence might change how we prevent disease rather than simply react to it.
He founded and directs the Scripps Research Translational Institute, where the emphasis is clear: translate discovery into real human benefit. Not hype. Not products. Not a quick fix. In a landscape crowded with longevity influencers and supplement stacks, Topol stands apart. He does not take sponsorships to push powders or pills. He is not interested in monetizing fear. If anything, he seems slightly allergic to the noise.
His focus is more austere and, in many ways, more radical. Diet. Sleep. Exercise. Social connection. The fundamentals. He talks about “super agers,” people who reach their eighties with the physiology of someone decades younger, and he does so with data in hand. What patterns do they share? What biomarkers remain resilient? How does inflammation behave across time? For Topol, longevity is not about chasing immortality. It is about compressing morbidity, extending healthspan, and preserving function.
In his recent writing, particularly in his book Super Agers, he leans into the evidence that aging is not a single uniform decline but a mosaic. Some systems falter early. Others remain robust. With genomic insight and longitudinal data, medicine can begin to map this mosaic and intervene earlier. But he is careful. He does not promise magic. He points instead to measurable behaviors: regular aerobic activity, resistance training, high-quality sleep, nutrient-dense food, minimizing ultra-processed diets. He is skeptical of supplement culture because most of it runs ahead of the evidence. If a molecule works, he believes, it should prove itself in rigorous trials.
There is also a democratizing instinct in his work. He has been outspoken about the need to make genomic testing and advanced diagnostics more accessible. He sees a future where medicine is individualized, where a person’s risk for atrial fibrillation or Alzheimer’s disease can be flagged early, and where prevention is not reserved for the affluent. He is equally vocal about the ethical tensions of AI in healthcare. Algorithms must augment clinicians, not replace empathy. Data must serve patients, not corporations.
When I photographed him, I was struck by the absence of cynicism. He has seen enough of the system to justify it. Yet he still believes that medicine can be reoriented toward prevention and personalization without losing its human core. There is a steadiness in him that mirrors his message. No flashy claims. No performative biohacking. Just the disciplined accumulation of evidence and a commitment to follow it wherever it leads.
In the end, Eric Topol represents a particular kind of authority that feels increasingly rare. Not the authority of charisma, but of rigor. Not the seduction of miracle cures, but the persistence of science. In a culture that wants shortcuts, he keeps returning to first principles. Move your body. Sleep deeply. Eat real food. Stay connected. Let the data guide you. And above all, protect the integrity of medicine from the distortions of commerce.
Standing in that quiet room at Scripps, you sense that his project is larger than longevity. It is about restoring trust in the idea that health is built, patiently and measurably, over time.
"Inteligencia Artificial y el futuro de los humanos" moderado por Alfredo Marcos, Catedrático de Filosofía de la Ciencia.
When I met Eric Topol at Scripps Research, he greeted me with an easy calm, the sort of quiet steadiness that settles a room without ever trying to command it. There is no theatricality about him. No hint of the celebrity doctor, even though he easily could play that role. His curiosity comes first. You feel it immediately. He listens closely, as if the next idea might arrive from anywhere.
Topol has spent decades at the frontier of cardiovascular medicine, genomics, and digital health. He trained as a cardiologist at a time when heart attacks were often a sudden, devastating surprise. Much of his early work focused on clot-busting therapies and transforming acute cardiac care. That alone would have secured a distinguished career. But he did not stop there. He moved into genetics and then into the rapidly evolving intersection of medicine and data, asking how sequencing, wearable sensors, and artificial intelligence might change how we prevent disease rather than simply react to it.
He founded and directs the Scripps Research Translational Institute, where the emphasis is clear: translate discovery into real human benefit. Not hype. Not products. Not a quick fix. In a landscape crowded with longevity influencers and supplement stacks, Topol stands apart. He does not take sponsorships to push powders or pills. He is not interested in monetizing fear. If anything, he seems slightly allergic to the noise.
His focus is more austere and, in many ways, more radical. Diet. Sleep. Exercise. Social connection. The fundamentals. He talks about “super agers,” people who reach their eighties with the physiology of someone decades younger, and he does so with data in hand. What patterns do they share? What biomarkers remain resilient? How does inflammation behave across time? For Topol, longevity is not about chasing immortality. It is about compressing morbidity, extending healthspan, and preserving function.
In his recent writing, particularly in his book Super Agers, he leans into the evidence that aging is not a single uniform decline but a mosaic. Some systems falter early. Others remain robust. With genomic insight and longitudinal data, medicine can begin to map this mosaic and intervene earlier. But he is careful. He does not promise magic. He points instead to measurable behaviors: regular aerobic activity, resistance training, high-quality sleep, nutrient-dense food, minimizing ultra-processed diets. He is skeptical of supplement culture because most of it runs ahead of the evidence. If a molecule works, he believes, it should prove itself in rigorous trials.
There is also a democratizing instinct in his work. He has been outspoken about the need to make genomic testing and advanced diagnostics more accessible. He sees a future where medicine is individualized, where a person’s risk for atrial fibrillation or Alzheimer’s disease can be flagged early, and where prevention is not reserved for the affluent. He is equally vocal about the ethical tensions of AI in healthcare. Algorithms must augment clinicians, not replace empathy. Data must serve patients, not corporations.
When I photographed him, I was struck by the absence of cynicism. He has seen enough of the system to justify it. Yet he still believes that medicine can be reoriented toward prevention and personalization without losing its human core. There is a steadiness in him that mirrors his message. No flashy claims. No performative biohacking. Just the disciplined accumulation of evidence and a commitment to follow it wherever it leads.
In the end, Eric Topol represents a particular kind of authority that feels increasingly rare. Not the authority of charisma, but of rigor. Not the seduction of miracle cures, but the persistence of science. In a culture that wants shortcuts, he keeps returning to first principles. Move your body. Sleep deeply. Eat real food. Stay connected. Let the data guide you. And above all, protect the integrity of medicine from the distortions of commerce.
Standing in that quiet room at Scripps, you sense that his project is larger than longevity. It is about restoring trust in the idea that health is built, patiently and measurably, over time.
Stomatal imprint of spinach leaf. Spinach (and the other salad leaves I looked at) carried stomata on both upper and lower surfaces, unlike the houseplants Tradescantia, Chlorophytum and Schefflera.
In the BioHack Academy the focus is on making lab equipment accessible through the open source sharing of designs.
On 3 April 2018 the BioHack Academy students presented their final projects. Visitors could discover the future of food, materials and products during the end presentation of our students. The projects show the potential of biotechnology and its creative application. Roland van Dierendonck, head of the BioHack Academy introduced this year's BioHack Academy after which the students received the official BioHack Academy Award.
This years students are: Matthijs de Block (BE), Jahangir Jahanbahkshi (NL), Jan Köhler (DE/HN), Malu Lücking (DE), Laura Olalde (AR), Bart Peeters (NL), Anna Pelgrim (NL), Alexander Rose (UK), Nel Thomas (DK). More information on waag.org/biohack
Prepared section of stem of wood dicotyledon which came with the microscope.
It's about 4mm wide at its widest point. This image is composed of several images taken with the lowest magnification (4x) objective autostitched together.
Os Pequenos Inventores conheceram um pouco mais sobre o universo da genômica partir de materiais de dia a dia. Eles conseguiram visualizar o DNA de frutas a partir de métodos de baixo custo.
"Inteligencia Artificial y el futuro de los humanos" moderado por Alfredo Marcos, Catedrático de Filosofía de la Ciencia.
Photos from the first BioHack Academy at the Waag.
Learn how to design, grow and extract your own biomaterials using only Open Source hardware you fabricate yourself. Whether it's a new type of bio ink, bio polymer or bio fuel, we'll show you can grow it yourself and share the results with others.
My ketones seem to be in a pretty good spot whether exogenous or liver produced. My running has improved (faster pace, no recovery, daily running).
I struggle with making dinner my final food for the day. Each day that gets a bit easier, but 8pm-10pm the snacks call to me. Particularly peanuts and chocolate chips!
Here are my numbers (26 days on keto)
Weight: Down 5.2 lbs : current weight: 128.6 lbs
BodyFat: Down 2.7% : current body fat: 9.6%
Blood Sugar: 88
Ketones: 1.0 mmol/L
Now I suspect my blood sugar is lower, but in order to avoid getting light headed during exercise I will often need a small amount of carbs (7g) is usually plenty for a 1-2 hour workout. #ketogenic #ketosis #keto #ketone #blood #ultrarunning #diet #biohacking #hflc #endurance #paleo #quantifiedself #burnfat
31 Likes on Instagram
4 Comments on Instagram:
5footking: Ummm wow! That's outstanding 👍👊👏!!
fermentedfoodguy: I am definitely not going into acidosis only ketosis. I am doing it for the mental clarity, avoiding bonking in races and sustained energy. It works great when I stay on the diet.
On 2 April 2019, all students of this year's BioHack Academy presented their work at Waag and received the official BioHack Academy Award.
"Inteligencia Artificial y el futuro de los humanos" moderado por Alfredo Marcos, Catedrático de Filosofía de la Ciencia.
When I met Eric Topol at Scripps Research, he greeted me with an easy calm, the sort of quiet steadiness that settles a room without ever trying to command it. There is no theatricality about him. No hint of the celebrity doctor, even though he easily could play that role. His curiosity comes first. You feel it immediately. He listens closely, as if the next idea might arrive from anywhere.
Topol has spent decades at the frontier of cardiovascular medicine, genomics, and digital health. He trained as a cardiologist at a time when heart attacks were often a sudden, devastating surprise. Much of his early work focused on clot-busting therapies and transforming acute cardiac care. That alone would have secured a distinguished career. But he did not stop there. He moved into genetics and then into the rapidly evolving intersection of medicine and data, asking how sequencing, wearable sensors, and artificial intelligence might change how we prevent disease rather than simply react to it.
He founded and directs the Scripps Research Translational Institute, where the emphasis is clear: translate discovery into real human benefit. Not hype. Not products. Not a quick fix. In a landscape crowded with longevity influencers and supplement stacks, Topol stands apart. He does not take sponsorships to push powders or pills. He is not interested in monetizing fear. If anything, he seems slightly allergic to the noise.
His focus is more austere and, in many ways, more radical. Diet. Sleep. Exercise. Social connection. The fundamentals. He talks about “super agers,” people who reach their eighties with the physiology of someone decades younger, and he does so with data in hand. What patterns do they share? What biomarkers remain resilient? How does inflammation behave across time? For Topol, longevity is not about chasing immortality. It is about compressing morbidity, extending healthspan, and preserving function.
In his recent writing, particularly in his book Super Agers, he leans into the evidence that aging is not a single uniform decline but a mosaic. Some systems falter early. Others remain robust. With genomic insight and longitudinal data, medicine can begin to map this mosaic and intervene earlier. But he is careful. He does not promise magic. He points instead to measurable behaviors: regular aerobic activity, resistance training, high-quality sleep, nutrient-dense food, minimizing ultra-processed diets. He is skeptical of supplement culture because most of it runs ahead of the evidence. If a molecule works, he believes, it should prove itself in rigorous trials.
There is also a democratizing instinct in his work. He has been outspoken about the need to make genomic testing and advanced diagnostics more accessible. He sees a future where medicine is individualized, where a person’s risk for atrial fibrillation or Alzheimer’s disease can be flagged early, and where prevention is not reserved for the affluent. He is equally vocal about the ethical tensions of AI in healthcare. Algorithms must augment clinicians, not replace empathy. Data must serve patients, not corporations.
When I photographed him, I was struck by the absence of cynicism. He has seen enough of the system to justify it. Yet he still believes that medicine can be reoriented toward prevention and personalization without losing its human core. There is a steadiness in him that mirrors his message. No flashy claims. No performative biohacking. Just the disciplined accumulation of evidence and a commitment to follow it wherever it leads.
In the end, Eric Topol represents a particular kind of authority that feels increasingly rare. Not the authority of charisma, but of rigor. Not the seduction of miracle cures, but the persistence of science. In a culture that wants shortcuts, he keeps returning to first principles. Move your body. Sleep deeply. Eat real food. Stay connected. Let the data guide you. And above all, protect the integrity of medicine from the distortions of commerce.
Standing in that quiet room at Scripps, you sense that his project is larger than longevity. It is about restoring trust in the idea that health is built, patiently and measurably, over time.
Stomatal imprint of Rocket leaf. Rocket (and the other salad leaves I looked at) carried numerous stomata on both upper and lower surfaces, unlike the houseplants Tradescantia, Chlorophytum and Schefflera.
ilovebuttercoffee.com/bulletproof-coupons/investment-mone...
If you have been following Dave Asprey over the years you would have noticed how much his personal and company brand, Bulletproof®, have grown over the years. It all started as a concept on how to make yak butter tea into yak butter coffee, then into butter coffee with coconut oil, then butter coffee with MCT oil in order to get the maximum ketone benefit for weight loss and reducing brain fog.
Well since that initial cup of low carb high fat coffee Dave has managed to turn his passion into a multi-million dollar business. People are flocking to his online store and we can see a glimpse by how many people love to use his monthly promo codes and coupon codes we have listed here. No public sales figures are disclosed as the company, based in Seattle, is privately owned and so doesn’t disclose income and expenditure figures. However, in 2015 there was multi million US dollar injection. Make it more like $9 million cash flow injection.
Source: Trinity Ventures
Trinity investment’s Gus Tai explained the venture capital companies reasons for deciding to invest a large sum of money into Dave’s company and Bulletproof health products. You can read all their reasons in this article “Trinity Backs Dave Asprey’s Bulletproof With $9M For Butter Coffee, Nootropics” on Tech Crunch Jul 23 2015.
It is great to see investors money flowing into companies that can help make people healthier. It is especially unique seeing that a lot of what Dave recommends when it comes to losing weight in the short and long-term is to use fat! Yes, the apparently deadly, horrible, supposed weight gaining stuff that the US and other governments from around the world have told people, for decades, to limit dramatically in their monthly grocery shopping bills and daily intake.
In the decades before the US standard diet food pyramid came into effect people use to consume large amounts butter and lard per annum. That all changed when state wide nutrition policy changed. However, the tide has turned dramatically! Sales of butter have now soared past alternatives like margarine. News articles and latest research since about 2010 have started showing how maybe we got it all wrong about fat. Turns out the good natural saturated fats like butter and coconut oil are good for our heart health.
It is easy to see why a company, like Trinity Ventures, wants to jump the gun and be an early adopter in an upcoming business that is leading the way when it comes to producing and distributing healthy fat products.
The money appears to have helped Dave expand his growing health product line including the new Fat Water range. The money is also being used to start converting the online ecommerce business into a retail one with shop fronts in the form of coffee shops.
The first ever Bulletproof coffee shop opened its doors in Santa Monica. You can take a tour of what it looks like in the side by watching the video below. The funny thing is this coffee shop is in the same business premises as where a Starbucks franchise used to be. Could Dave be the next Starbucks? I’m sure he is hoping to be.
So it is great to see the biohacking community grow and help move the ketogenic diet movement into the next level of mainstream society. I can see it helping to alleviate so many common lifestyle diseases like obesity and diabetes that are economically draining away the available healthcare resources and personal incomes of so many people. Not only the population of the United States, but internationally in other countries like the United Kingdom, Australia, South Africa, France, Germany, Spain, Brazil, Japan, Hong Kong, Singapore etc…
The post Investment Money is Pouring Into the Bulletproof Coffee Lifestyle Concept appeared first on Bulletproof Coffee.